. . . "Of 29 patients with the Proteus syndrome, 26 had a somatic activating mutation (c.49G???A, p.Glu17Lys) in the oncogene AKT1, encoding the AKT1 kinase, an enzyme known to mediate processes such as cell proliferation and apoptosis." . .